stars 1 stars 2 stars 3

At Corion Biotech S.r.l. we are committed to develop innovative therapeutic solutions for Women's health. Our technology is based on a specific cell population derived from the human term placenta. By our property technology, we exploit the unique placental therapeutic abilities in-vitro to develop our "Cell Therapy without Cells". A therapy based on Placental cells-derived biologicals instead of a direct administration of living cells to the patient is a totally new approach which maintains the effectiveness of cell therapy avoiding the risk of direct administration of living allogenic cells. Our approach is the most ethical, safe and effective solution present in the Advanced Therapy Medicinal Products panorama.

Corion Biotech S.r.l. Questions

The Corion Biotech S.r.l. annual revenue was $3 million in 2026.

Tullia Todros is the Founder and CEO Corion Biotech of Corion Biotech S.r.l..

3 people are employed at Corion Biotech S.r.l..

Corion Biotech S.r.l. is based in Turin, Piedmont.

The NAICS codes for Corion Biotech S.r.l. are [5417, 541, 54, 54171, 541713].

The SIC codes for Corion Biotech S.r.l. are [87, 873].

Top Corion Biotech S.r.l. Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users